Inamul Haque

2.5k total citations
70 papers, 2.0k citations indexed

About

Inamul Haque is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Inamul Haque has authored 70 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in Inamul Haque's work include Connective Tissue Growth Factor Research (16 papers), Thermodynamic properties of mixtures (8 papers) and Biomarkers in Disease Mechanisms (7 papers). Inamul Haque is often cited by papers focused on Connective Tissue Growth Factor Research (16 papers), Thermodynamic properties of mixtures (8 papers) and Biomarkers in Disease Mechanisms (7 papers). Inamul Haque collaborates with scholars based in United States, India and Iran. Inamul Haque's co-authors include Sushanta K. Banerjee, Snigdha Banerjee, Faizan Ahmad, John L. Wood, Smita Mehta, Ali Akbar Moosavi‐Movahedi, Suman Kambhampati, Archana De, Kakali Dhar and Peter J. Van Veldhuizen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Inamul Haque

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inamul Haque United States 29 904 227 222 207 200 70 2.0k
Jie Yu China 24 660 0.7× 185 0.8× 158 0.7× 103 0.5× 130 0.7× 96 2.0k
Xuejun Zhang China 29 939 1.0× 181 0.8× 120 0.5× 907 4.4× 42 0.2× 69 2.6k
Guangyan Du China 26 826 0.9× 59 0.3× 229 1.0× 791 3.8× 82 0.4× 76 2.0k
A. MAUREEN ROUHI Germany 21 933 1.0× 416 1.8× 125 0.6× 255 1.2× 41 0.2× 105 1.8k
Jian Gao China 20 587 0.6× 102 0.4× 116 0.5× 249 1.2× 36 0.2× 94 1.4k
Qi Sun China 31 789 0.9× 51 0.2× 159 0.7× 444 2.1× 43 0.2× 126 2.6k
Jong‐Min Kim South Korea 27 720 0.8× 179 0.8× 160 0.7× 72 0.3× 16 0.1× 67 2.0k
Mei Liu China 31 1.4k 1.6× 107 0.5× 106 0.5× 795 3.8× 25 0.1× 119 3.0k
Arindam Chatterjee India 18 500 0.6× 132 0.6× 135 0.6× 782 3.8× 11 0.1× 58 1.4k
Michael Wagner Germany 30 936 1.0× 46 0.2× 166 0.7× 757 3.7× 14 0.1× 117 2.6k

Countries citing papers authored by Inamul Haque

Since Specialization
Citations

This map shows the geographic impact of Inamul Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inamul Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inamul Haque more than expected).

Fields of papers citing papers by Inamul Haque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inamul Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inamul Haque. The network helps show where Inamul Haque may publish in the future.

Co-authorship network of co-authors of Inamul Haque

This figure shows the co-authorship network connecting the top 25 collaborators of Inamul Haque. A scholar is included among the top collaborators of Inamul Haque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inamul Haque. Inamul Haque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ray, Priyanka, Debasmita Dutta, Inamul Haque, et al.. (2020). pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer. Molecular Pharmaceutics. 18(1). 87–100. 37 indexed citations
2.
Maity, Gargi, Arnab Ghosh, Inamul Haque, et al.. (2019). CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 18(4). 788–800. 30 indexed citations
3.
Mahanta, Lipi B., et al.. (2018). Study on Contribution of Biological Interpretable and Computer-Aided Features Towards the Classification of Childhood Medulloblastoma Cells. Journal of Medical Systems. 42(8). 151–151. 11 indexed citations
4.
Haque, Inamul, Arnab Ghosh, Snigdha Banerjee, et al.. (2018). Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer. 18(1). 99–99. 45 indexed citations
5.
Haque, Inamul, Arvind Subramanian, Snigdha Banerjee, & Sushanta K. Banerjee. (2017). Current and emerging perspectives on immunotherapy for pancreatic cancer. Translational Cancer Research. 6(2). 1 indexed citations
6.
Sarkar, Sandipto, Arnab Ghosh, Snigdha Banerjee, et al.. (2017). CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen. Oncogenesis. 6(5). e340–e340. 20 indexed citations
7.
Das, Amlan, Kakali Dhar, Gargi Maity, et al.. (2017). Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth. Scientific Reports. 7(1). 1220–1220. 22 indexed citations
8.
Haque, Inamul, et al.. (2017). Racial disparity in breast cancer: can it be mattered for prognosis and therapy. Journal of Cell Communication and Signaling. 12(1). 119–132. 18 indexed citations
9.
10.
Kambhampati, Suman, Roger A. Rajewski, Inamul Haque, et al.. (2013). A Second-Generation 2-Methoxyestradiol Prodrug Is Effective against Barrett's Adenocarcinoma in a Mouse Xenograft Model. Molecular Cancer Therapeutics. 12(3). 255–263. 22 indexed citations
11.
De, Alok, Archana De, Shane T. Hentges, et al.. (2013). Emblica officinalis Extract Induces Autophagy and Inhibits Human Ovarian Cancer Cell Proliferation, Angiogenesis, Growth of Mouse Xenograft Tumors. PLoS ONE. 8(8). e72748–e72748. 65 indexed citations
12.
Haque, Inamul, Archana De, Smita Mehta, et al.. (2012). The Matricellular Protein CCN1/Cyr61 Is a Critical Regulator of Sonic Hedgehog in Pancreatic Carcinogenesis. Journal of Biological Chemistry. 287(46). 38569–38579. 44 indexed citations
13.
14.
Kambhampati, Suman, et al.. (2011). Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells. Journal of Cell Communication and Signaling. 5(4). 317–324. 25 indexed citations
15.
Kambhampati, Suman, Snigdha Banerjee, Kakali Dhar, et al.. (2010). 2-Methoxyestradiol Inhibits Barrett's Esophageal Adenocarcinoma Growth and Differentiation through Differential Regulation of the β-Catenin–E-Cadherin Axis. Molecular Cancer Therapeutics. 9(3). 523–534. 10 indexed citations
16.
Haque, Inamul, Gregory L. Bomhoff, Hiroo Katayama, et al.. (2009). Identifying protein stabilizing ligands using GroEL. Biopolymers. 93(3). 237–251. 8 indexed citations
17.
Singh, Laishram Rajendrakumar, Tanveer Ali Dar, Inamul Haque, et al.. (2007). Testing the paradigm that the denaturing effect of urea on protein stability is offset by methylamines at the physiological concentration ratio of 2:1 (urea:methylamines). Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1774(12). 1555–1562. 38 indexed citations
18.
Haque, Inamul, et al.. (2005). Effect of polyol osmolytes on ΔGD, the Gibbs energy of stabilisation of proteins at different pH values. Biophysical Chemistry. 117(1). 1–12. 88 indexed citations
19.
Haque, Inamul, et al.. (2005). Counteracting Osmolyte Trimethylamine N-Oxide Destabilizes Proteins at pH below Its pK. Journal of Biological Chemistry. 280(12). 11035–11042. 99 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Yu Breakdown of academic impact, for papers by Xuejun Zhang Breakdown of academic impact, for papers by Guangyan Du Breakdown of academic impact, for papers by A. MAUREEN ROUHI Breakdown of academic impact, for papers by Jian Gao Breakdown of academic impact, for papers by Qi Sun Breakdown of academic impact, for papers by Jong‐Min Kim Breakdown of academic impact, for papers by Mei Liu Breakdown of academic impact, for papers by Arindam Chatterjee Breakdown of academic impact, for papers by Michael Wagner
Rankless by CCL
2026